Biotechnology
Understanding the Biotech Industry. A Quality of Ernst & Young. As the industry comes of age, biotechnology companies around the world face unprecedented challenges including building commercial infrastructure and launching products, increased regulatory oversight, pricing pressures, access to capital, acquisitions, and alliances.
Our 30 years of service to the biotechnology industry gives us the knowledge and perspective to help companies address these challenges. Worldwide, our professionals assist biotechnology executives and their boards by providing assurance, risk, tax, transaction, and finance-related services. Our involvement with, and dedication to, the industry is further enriched by our annual publication "Beyond Borders: The Global Biotechnology Annual Report", now in its 20st year, and the Ernst & Young Global Biotechnology Center, where we connect our global network of professionals to help them deliver seamless, consistent, high-quality service.
/$FILE/14L00232.JPG)
Swiss Biotech Report – Update 2009